These were recorded, transcribed, and analyzed using deductive (coded to implementation outcomes) and inductive (themes based on focus group discussions) methods. Focus groups were conducted with 22 individuals with FH (2 groups) and 20 clinicians (3 groups). Guided by the Conceptual Model of Implementation Research, we explored the acceptability, appropriateness, and feasibility of: (1) automated screening approaches utilizing existing health data to identify those who require subsequent diagnostic evaluation for familial hypercholesterolemia (FH) and (2) family communication methods including chatbots and direct contact to communicate information about inherited risk for FH. Authors may use MDPI'sĮnglish editing service prior to publication or during author revisions. Submitted papers should be well formatted and use good English. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Please visit the Instructions for Authors page before submitting a manuscript.

Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. All manuscripts are thoroughly refereed through a single-blind peer-review process. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Research articles, review articles as well as short communications are invited. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. All submissions that pass pre-check are peer-reviewed. Manuscripts can be submitted until the deadline. Once you are registered, click here to go to the submission form. Manuscripts should be submitted online at by registering and logging in to this website. Communications, reviews, and original articles are welcome. Papers may address use of electronic health records for genomic discovery and implementation, digital tools for genomic medicine including clinical decision support, genomic medicine in low-resource-constrained settings, use of whole genome/exome sequencing such as in diagnostic odysseys, variant interpretation and functional assays, cascade testing, polygenic risk scores for cardiovascular disease and their integration into clinical practice, population screening, and team-based genomic medicine programs. Executive Produced by Robert Downey Jr., Susan Downey, and Emily Barclay Ford for Team Downey and C13Originals, together with Josh McLaughlin for Wink Pictures and written, produced, and directed by Peabody-nominated C13Originals, a Cadence13 Studio.This Special Issue of the Journal of Personalized Medicine titled “Genomic Medicine for Cardiovascular Disease” aims to highlight the state-of-the-art for genomic medicine in clinical cardiovascular practice, highlighting innovative and novel approaches. The Sunshine Place tells the mind-blowing, true-story of Synanon - one of America’s most cutting edge social experiments, turned into one of its most dangerous and violent cults - as it’s never been told before: by the people who lived it. Dederich, aka “Chuck,” would be the one to destroy it all, along with the lives of many of his followers and millions of dollars in assets.

The man who made the miracle happen, Charles E. What started in a house on the beach, soon spread to compounds across the country.

Before long, it would make an even bolder claim: It could cure any of your problems. Once called “the miracle on the beach,” Synanon began in the 1960s as an experimental rehab facility in Santa Monica, California with a radical claim: It could cure heroin addiction.

Dr iftikar kullo